483
Syntenza Pharmaceuticals, LLCSyntenza Pharmaceuticals, LLC – FDA 483, Mar 12, 2020
Record Details
An FDA inspection of Syntenza Pharmaceuticals, LLC in Edina, MN, revealed a significant deficiency in their postmarketing adverse drug experience reporting system. The firm lacked written procedures for surveillance, receipt, evaluation, and reporting of adverse drug experiences. Furthermore, the firm demonstrated a lack of awareness and involvement with procedures prepared and activities conducted by a contractor under the firm's name, indicating a critical breakdown in oversight.
View Company Profile
ID · fd964e6f-1c5b-46c9-9fa3-595641e4053b
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.